#COVID-19 vaccine

A study from the Leukemia & Lymphoma Society finds that antibody production varies widely across blood cancer types.

Two new studies come to different conclusions about the risk for severe illness and death.

The results point the way toward a universal coronavirus vaccine that could prevent future pandemics.

In California, a reform group is suing, arguing that unprotected prison workers put vulnerable inmates at risk.

Only the Women’s National Basketball Association, at 99%, can boast a highly successful campaign to educate and vaccinate its players.

The nation fell just short of the White House’s goal to give at least a first dose to 70% of adults by Independence Day.

The immune response to the single-shot Johnson & Johnson vaccine remained robust against variants of SARS-CoV-2.

Some people with blood cancers, however, may not be as well protected.

These findings, however, may reflect regional attitudes in Utah and the surrounding area.

MOMI-VAX researchers will evaluate antibody responses in vaccinated participants and their infants.

Public health leaders hoped more well-known names would become role models for getting the vaccines.

Three decades ago, HIV advocates helped lay the groundwork for the response to COVID-19.

An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.

Federal regulators and the public must decide how much risk they are willing to accept from vaccines versus the risk of COVID-19.

To many people, lifting mask mandates seems hard to reconcile with so many long months of sacrificing our social lives for fear of COVID-19.